Showing posts with label march in rights. Show all posts
Showing posts with label march in rights. Show all posts
Tuesday, 20 February 2024

U.S. FTC Supports March-in Rights Guidelines

›
The U.S. Federal Trade Commission has released a comment in support of the NIST’s guidelines concerning the exercise of march-in rights unde...
Saturday, 20 November 2021

The U.S. Funding of the Moderna mRNA Technology and a Patent Dispute

›
Ana Santos Rutschman at Saint Louis University Law School has authored an interesting short article titled, "Why Moderna Won't Sha...
Wednesday, 14 July 2021

Biden Administration Executive Order on Competition: Some IP Portions

›
On July 9, 2021, the Biden Administration released an “Executive Order on Promoting Competition in the American Economy” that literally will...
Thursday, 20 May 2021

mRNA Vaccine Patents Study

›
Mario Gaviria and Burcu Kilic have published an interesting article titled, “A Network Analysis of Covid-19 mRNA Vaccine Patents.”  The arti...
Tuesday, 22 March 2016

The Pharmaceutical Pricing Problem: A Call to Exercise Bayh-Dole Act March-In Rights Heard?

›
The United States is struggling with the high cost of healthcare.   Notably, one cause of the high cost is the price of pharmaceuticals.  ...
Saturday, 20 July 2013

Myriad—Enforcement Continues and Now March-in Rights to Protect the Public?

›
Immediately after the U.S. Supreme Court issued the Myriad opinion, numerous competitors to Myriad announced that they would offer genetic ...
2 comments: